Despite a big increase in “watchful waiting” in the past 15 years, there’s a new study from the U.S. Department of Veterans Affairs health system shows that overtreatment of prostate cancer persists.
A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for ...
Black men have higher rates of stage 3 and stage 4 prostate cancer diagnosis compared to white men, a study has suggested. The analysis of data from the National Prostate Cancer Audit by the charity ...